Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- a Systematic Review

Unaiza Faizan, MD, Muhammad Saad Farooqi, MDMBBS, Hassaan Imtiaz, MD, Muhammad Yasir Anwar, Muhammad Khawar Sana, MD, Arafat Ali Farooqui, MD, Zahoor Ahmed, MD, Abdul Jabbar Dar, MD, Hamza Hashmi, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-141078

Published: 2020

Journal Articles

Safety and Efficacy of Purine Analogs for Treatment of Waldenstrom Macroglobulinemia

Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Muhaddis Ejaz Ahmad, MD, Muhammad Ali Mirza, MD, Farhan Khalid, MBBS, Muhammad Tayyeb, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Sana Irfan Khan, MD, Richi Kashyap, MD, Saad Javed, MD, Unaiza Faizan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-138750

Published: 2020

Journal Articles

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Muhammad Ali Mirza, MD, Muhaddis Ejaz Ahmad, MD, Sobia Aamir, MDFCPS, Richi Kashyap, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Israr Khan, Arshia Akbar, MDMBBS, Waqas Khan, Muhammad Tayyeb, MD, Sundas Ali, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-138964

Published: 2020

Journal Articles

A Systematic Review on Efficacy and Safety of Bortezomib Based Regimens for Treatment of Waldensterom Macroglobulinemia

Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Muhaddis Ejaz Ahmad, MD, Muhammad Ali Mirza, MD, Farhan Khalid, MBBS, Ali Jaan, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Atif Irfan Khan, MD, Richi Kashyap, MD, Anam Khan, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138718

Published: 2020

Journal Articles

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Abdul Rafae, MD, Moazzam Shahzad, MD, Muhammad Saad Farooqi, MDMBBS, Sundas Ali, MBBS, MD, Saad Javed, MD, Richi Kashyap, MD, Shaha Nabeel, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 36.

https://doi.org/10.1182/blood-2020-141761

Published: 2020

Journal Articles

Role of Adoptive T- Cell Therapy in Post Hematopoietic Stem Cells Transplant Viral Infections-: A Systemic Review

Hassaan Imtiaz, MD, Muhammad Saad Farooqi, MDMBBS, Unaiza Faizan, MD, Saad Ur Rehman, MD, Muhammed Hamza Arshad, MD, Ali Shahbaz Baloch, MD, Syed Shahnawaz Hashmi, MD, Abdullah Jamal, MBBS, Taimoor Jaffar Ali, MBBS, Ali Younas Khan, MD, Zahoor Ahmed, MD, Abdul Jabbar Dar, MD, Muhammad Ali Mirza, MD, Qasim Khurshid, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 14–16.

https://doi.org/10.1182/blood-2020-139284

Published: 2020

Journal Articles

Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review

Muhammad Saad Farooqi, MDMBBS, Unaiza Faizan, MD, Saad Ur Rahman, MBBS, Hassaan Imtiaz, MD, Muhammed Hamza Arshad, MD, Arafat Ali Farooqui, MD, Zahoor Ahmed, MD, Muhammad Ali Aziz, MD, Ali Jaan, MD, Ali Shahbaz Baloch, MD, Naurez Qasim, MD, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137139

Published: 2020

Journal Articles

Efficacy of Chemotherapeutic Regimens for Mantle Cell Lymphoma: A Systematic Review of Phase III Trials

Ali Jaan, MD, Muhammad Tayyeb, MD, Farhan Khalid, MBBS, Muhammad Khawar Sana, MD, Zahoor Ahmed, MD, Muhammad Saad Farooqi, MDMBBS, Mydah Sajid Hashmi, MD, Syed Maaz Abdullah, MBBS, Sundas Ali, Umar Farooque, MBBS, Saad Javed, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-141181

Published: 2020

Journal Articles

A Systematic Review and Meta-Analysis of Luspatercept for Anemia Treatment in Low Risk Myelodysplastic Syndrome with Ring Sideroblast Subtype in Phase II and Phase III Clinical Trials

Arshia Akbar, MDMBBS, Waqas Khan, Zunairah Shah, MBBS, Muhammad Yasir Anwar, Muhammad Ali Aziz, MD, Zahoor Ahmed, MD, Muhammad Saad Farooqi, MDMBBS, Ali Shahbaz Baloch, MD, Mydah Sajid Hashmi, MD, Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Saman Bahram, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-137152

Published: 2020

NARROW

Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- a Systematic Review

Safety and Efficacy of Purine Analogs for Treatment of Waldenstrom Macroglobulinemia

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

A Systematic Review on Efficacy and Safety of Bortezomib Based Regimens for Treatment of Waldensterom Macroglobulinemia

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Role of Adoptive T- Cell Therapy in Post Hematopoietic Stem Cells Transplant Viral Infections-: A Systemic Review

Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review

Efficacy of Chemotherapeutic Regimens for Mantle Cell Lymphoma: A Systematic Review of Phase III Trials

A Systematic Review and Meta-Analysis of Luspatercept for Anemia Treatment in Low Risk Myelodysplastic Syndrome with Ring Sideroblast Subtype in Phase II and Phase III Clinical Trials

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only